Hadasit Bio-Holdings Ltd
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings L… Read more
Hadasit Bio-Holdings Ltd (HSITF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.159x
Based on the latest financial reports, Hadasit Bio-Holdings Ltd (HSITF) has a cash flow conversion efficiency ratio of -0.159x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-455.50K) by net assets ($2.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hadasit Bio-Holdings Ltd - Cash Flow Conversion Efficiency Trend (2012–2023)
This chart illustrates how Hadasit Bio-Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hadasit Bio-Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hadasit Bio-Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arn. Georg AG
DU:ARN
|
N/A |
|
Amanet Management & Systems Ltd
TA:AMAN
|
-0.030x |
|
EXLSERVICE HLDG
BE:LHV
|
0.121x |
|
Direxion Daily AVGO Bull 2X Shares
NASDAQ:AVL
|
N/A |
|
Cementos Molins SA
MC:CMO
|
N/A |
|
Maximus Resources Ltd
AU:MXR
|
0.000x |
|
Quality Distribution Inc
NASDAQ:QLTY
|
-0.241x |
|
Bkm Industries Limited
NSE:BKMINDST
|
-1.155x |
Annual Cash Flow Conversion Efficiency for Hadasit Bio-Holdings Ltd (2012–2023)
The table below shows the annual cash flow conversion efficiency of Hadasit Bio-Holdings Ltd from 2012 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $5.94 Million | $-1.98 Million | -0.333x | -452.57% |
| 2022-12-31 | $35.08 Million | $-2.12 Million | -0.060x | -88.52% |
| 2021-12-31 | $65.69 Million | $-2.10 Million | -0.032x | +70.05% |
| 2020-12-31 | $37.11 Million | $-3.96 Million | -0.107x | +81.53% |
| 2019-12-31 | $5.50 Million | $-3.18 Million | -0.578x | -20.50% |
| 2018-12-31 | $34.30 Million | $-16.46 Million | -0.480x | -65.93% |
| 2017-12-31 | $60.79 Million | $-17.57 Million | -0.289x | -21.36% |
| 2016-12-31 | $61.62 Million | $-14.68 Million | -0.238x | -8.35% |
| 2015-12-31 | $60.30 Million | $-13.26 Million | -0.220x | +60.29% |
| 2014-12-31 | $22.11 Million | $-12.24 Million | -0.554x | -18.68% |
| 2013-12-31 | $24.89 Million | $-11.61 Million | -0.467x | -27.27% |
| 2012-12-31 | $35.86 Million | $-13.15 Million | -0.367x | -- |